271980 — Jeil Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
KR₩179bn
Enterprise Value
KR₩229bn
Revenue
KR₩705bn

Annual balance sheet for Jeil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,588	28,003	31,589	35,658	57,455
Net Total Accounts Receivable
Net Total Receivables	156,922	146,689	153,267	166,225	174,516
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	277,513	284,672	291,641	317,046	343,036
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	115,547	125,710	138,402	137,041	146,166
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	409,663	426,486	456,892	487,326	525,700
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	218,058	221,943	268,657	318,170	291,690
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	237,269	258,273	298,983	328,756	337,550
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	172,394	168,213	157,909	158,570	188,150
Total Liabilities & Shareholders' Equity	409,663	426,486	456,892	487,326	525,700
Total Common Shares Outstanding